Fig. 4From: PIK3CA mutations are common in lobular carcinoma in situ, but are not a biomarker of progression a Sub-clonal segments on copy number analysis; b microsatellite markers confirm that sub-clonal segments on copy number analysis show heterogeneous loss. (LOH = loss of heterozygosity)Back to article page